TF-TMVR USING 29MM SAPIEN-3 VALVE – November 12 , 2019

90-year-old female with HTN, CKD-3, s/p CABG, RHD with s/p bio-prosthetic MVR (31mm bovine tissue valve in 2003) for severe mitral regurgitation and LAA resection now presents with fatigue, exertional dyspnea and pedal edema. EKG showed A-fib with controlled ventricular rate. Recent TTE on 9/19/19 showed moderate to severe bioprosthetic mitral stenosis with mild MR, moderate TR and moderate-severe pulmonary hypertension. TEE on 10/16/19 showed severe prosthetic mitral stenosis (PG/MG 22/11mm Hg, MVA of 1.2cm2), mod-to-severe TR and moderate pulmonary hypertension. CT scan showed MVA of 1.2cm2 with neo-LVOT area of 288 sq. cm and aorto-mitral angle was 1370. Her STS, Euro score and logistic Euro score were 15.1, 14.7 and 31.4 respectively. Heart Team evaluation found her to be extreme risk for redo MVR due to associated medical comorbidities. Now planned for TF-TMVR via right percutaneous femoral venous access using a 29 mm SAPIEN-3 valve.

Comments

One Comment
Anoop
12 Nov, 2019

Excellent demonstration of the novel TMVR. Can you please share clinical follow up of the patient with respect to any late issues with residual ASD? Thanks

Reply

Leave a Reply

Your email address will not be published.*


Warning: Invalid argument supplied for foreach() in /home/468933.cloudwaysapps.com/wrezgzxbge/public_html/wp-content/plugins/constant-contact-forms/includes/class-settings.php on line 1087

Yes, I would like to receive emails from Mount Sinai Hospital. Sign me up!


By submitting this form, you are consenting to receive marketing emails from: Mount Sinai Hospital, One Gustave L. Levy Place, Box, New York, NY, 10029, https://ccclivecases.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact